Relay Therapeutics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $15.4 | $10.0 | $25.5 | $1.4 | $3.0 |
| Operating income | -$302.7 | -$372.5 | -$373.0 | -$299.3 | -$364.7 |
| Net income | -$276.5 | -$337.7 | -$342.0 | -$290.5 | -$363.9 |
| Cash Flow Statement | |||||
| Free cash flow | -$235.9 | -$251.1 | -$304.4 | -$238.6 | -$77.9 |
| Dividends | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Shares outstanding 219.1M · Free float 54.5%
Annual filing data through FY ended December 31, 2025; float as of October 5, 2026.